1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > China Vitamin Industry Report,2014-2017

China Vitamin Industry Report,2014-2017

  • June 2014
  • -
  • Research In China
  • -
  • 117 pages

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.

China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.

Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.

In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.

Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.

"China Vitamin Industry Report, 2014-2017" provided by ResearchInChina covers the following:

China vitamin market supply and demand, import and export, competition pattern and development projections;
Development status, competition pattern, import and export, market prices of VC, VA, VB, VE products in China;
Operation, vitamin business and development prospects of 16 global and Chinese vitamin companies.

Table Of Contents

China Vitamin Industry Report,2014-2017
1 Overview of Vitamins
1.1 Definition
1.2 Classification
1.3 Global Overview

2 Development of China Vitamin Industry
2.1 Status Quo
2.2 Import and Export
2.2.1 Export
2.2.2 Import
2.3 Competition Pattern

3 China Vitamin Market Segments
3.1 VA
3.1.1 Development Status
3.1.2 Import and Export
3.1.3 Market Price
3.2 VB
3.2.1 D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5)
3.2.2 VB6
3.2.3 VB1
3.2.4 VB2
3.2.5 Choline Chloride (VB4)
3.2.6 VB12
3.3 VC
3.3.1 Development Status
3.3.2 Import and Export
3.3.3 Market Price
3.4 VE
3.4.1 Development Status
3.4.2 Import and Export
3.4.3 Market Price
3.5 Others

4 Key Enterprises
4.1 DSM
4.1.1 Profile
4.1.2 Operation
4.1.3 Vitamin Business
4.1.4 RandD
4.1.5 Business in China
4.2 BASF
4.2.1 Profile
4.2.2 Operation
4.2.3 Vitamin Business
4.2.4 Business in China
4.3 Adisseo
4.3.1 Profile
4.3.2 Vitamin Business
4.3.2 R and D
4.4 CSPC Pharmaceutical Group Limited
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Vitamin Business
4.4.5 R and D
4.5 Shandong Xinhua Pharmaceutical
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Vitamin Business
4.5.5 R and D
4.5.6 Major Clients
4.6 North China Pharmaceutical
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.5.4 Vitamin Business
4.6.5 R and D
4.6.6 Major Clients
4.7 PKU Healthcare
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Vitamin Business
4.7.5 R and D
4.7.6 Major Clients
4.8 Zhejiang Medicine Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Vitamin Business
4.8.5 R and D
4.8.6 Major Clients
4.9 Northeast Pharmaceutical
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Vitamin Business
4.9.5 R and D
4.9.6 Major Clients
4.10 Hubei Guangji Pharmaceutical
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Vitamin Business
4.10.5 R and D
4.10.6 Major Clients
4.11 NHU
4.11.1Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Vitamin Business
4.11.5 R and D
4.11.6 Major Clients
4.12 Brother Enterprises Holding
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Vitamin Business
4.12.5 R and D
4.12.6 Major Clients
4.13 Zhejiang Hangzhou Xinfu Pharmaceutical
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Vitamin Business
4.13.5 R and D
4.13.6Major Clients
4.14 Kingdomway
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 R and D
4.14.5 Major Clients
4.15 Henan Topfond Pharmaceutical Co.,Ltd
4.15.1 Profile
4.15.2 Operation
4.15.3 Vitamin Business
4.15.4 R and D
4.16 Xinfa Pharmaceutical
4.16.1 Profile
4.16.2 Operation

5 Forecast and Outlook
5.1 Output and Product Mix
5.2 Competition Pattern

Companies Mentioned

DSM
BASF
Adisseo
CSPC Pharmaceutical Group Limited
Shandong Xinhua Pharmaceutical
North China Pharmaceutical
PKU Healthcare
Zhejiang Medicine Co., Ltd.
Northeast Pharmaceutical
Hubei Guangji Pharmaceutical
NHU
Brother Enterprises Holding
Zhejiang Hangzhou Xinfu Pharmaceutical
Kingdomway
Henan Topfond Pharmaceutical Co.,Ltd
Xinfa Pharmaceutical

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Water-Soluble Vitamin & Mineral Feed Supplements Market by Vitamin Type, Mineral Type, Livestock - Global Forecast to 2022

Water-Soluble Vitamin & Mineral Feed Supplements Market by Vitamin Type, Mineral Type, Livestock - Global Forecast to 2022

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

“The water soluble vitamin & mineral feed supplements market is projected to grow at a CAGR of 7.24% and 4.76% respectively” The global water-soluble vitamin supplements market is projected to grow ...

Folic Acid Market Analysis By Application (Food & Beverages, Pharmaceuticals, Nutraceuticals), By Region (North America, Europe, Asia-Pacific, MEA, CSA), Trends & Dynamics, Competitive Landscape And Segment Forecasts, 2014 - 2025

Folic Acid Market Analysis By Application (Food & Beverages, Pharmaceuticals, Nutraceuticals), By Region (North America, Europe, Asia-Pacific, MEA, CSA), Trends & Dynamics, Competitive Landscape And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global folic acid market is expected to reach USD 666.2 million by 2025, according to a new report by Grand View Research, Inc. Growing consumption of vitamin B9 as a source of an essential supplement ...

Global Over The Counter Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin (2017 - 2022)

Global Over The Counter Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin (2017 - 2022)

  • $ 4750
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...


Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

Milk Industry

  • March 2017
    12 pages
  • Milk  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

Fish Oil Industry

22 days ago

Otc Markets In Europe

24 days ago

Related Market Segments :

Vitamin

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.